The FANCN Protein encodes a protein involved in critical cellular processes related to DNA repair and genomic stability. This gene has been studied in the context of neurodegenerative diseases including Parkinson's disease and ALS, as well as various cancer predisposition syndromes.
| FANCN (PALB2) Protein | |
|---|---|
| Protein Name | Partner and localizer of BRCA2 |
| Alternative Names | PALB2, FANCN |
| Molecular Weight | 130 kDa |
| Length | 1186 amino acids |
| UniProt ID | Q86X2 |
| Cellular Location | Nucleus |
FANCN, also known as PALB2 (Partner And Localizer of BRCA2), is a critical scaffold protein in the Fanconi anemia DNA repair pathway. It serves as a molecular hub that connects the upstream FA core complex to the downstream homologous recombination machinery, particularly BRCA2 and RAD51. Pathogenic variants in FANCN cause Fanconi anemia type N and significantly increase the risk of breast, ovarian, and pancreatic cancers.
FANCN/PALB2 contains multiple functional domains:
FANCN interacts with:
Research on FANCN Protein has revealed important connections between DNA repair mechanisms and neurodegenerative diseases. Studies have shown that variants in DNA repair genes can influence susceptibility to Parkinson's disease and ALS, potentially through effects on mitochondrial function and cellular stress responses.
The protein encoded by this gene plays a role in maintaining genomic stability, and dysregulation may contribute to the accumulation of DNA damage in neurons over time. This has implications for understanding the molecular basis of neurodegeneration and developing therapeutic interventions.